The True Coronavirus Toll in the U.S. Has Already Surpassed 200,000
A New York Times analysis shows a high number of deaths above normal — with the most recent rise in excess deaths focused in the South and West.
Related Articles
Opinion | The Courage to Follow the Evidence on Transgender Care
Dr. Hilary Cass’s thoughtful medical review is a model for how we should address difficult issues.
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem (Gift Article)
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
Meta, in Its Biggest A.I. Push, Places Smart Assistants Across Its Apps
Users of Instagram, Facebook, WhatsApp and Messenger will be able to turn to the new technology, powered by Meta’s latest artificial intelligence model, to obtain…
Opinion | The Miracle Weight-Loss Drug Is Also a Major Budgetary Threat
Ozempic threatens to bust the national budget. That may finally force the government to address the problem of overly expensive medical treatments.
Live Updates: Police Arresting Pro-Palestinian Protesters at Columbia
Officers announced that they would begin arresting students who had pitched tents on campus Wednesday, the same day that university officials testified about antisemitism before…
David Egilman, Doctor Who Took On Drug Companies, Dies at 71
His testimony as an expert witness in some 600 trials helped plaintiffs win billions of dollars in cases involving malfeasance by pharmaceutical makers.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
Colorado Bill Aims to Protect Consumer Brain Data
In a first, the legislation extends privacy rights to the neural data increasingly coveted by technology companies.
Colorado Bill Aims to Protect Consumer Brain Data
In a first, the legislation extends privacy rights to the neural data increasingly coveted by technology companies.
